Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 7 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
    S. Leo, I. Dhoparee-Doomah, S. Negi +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Droplet-based organoid screens enable high-throughput identification of cancer vulnerabilities
    Y.-N. Xia, Y. Sun, Y. Wang +10
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. SPEAR: Spatial Epitranscriptomic Analysis by Mass Spectrometry Reveals Localized RNA Modification Remodeling During Glioma Progression
    S. Mateus, A. Attina, K. Bigot +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. MCT4-Associated Lactate Export Defines Myeloid Metabolic Reprogramming during Head and Neck Cancer Progression
    T. Tilton, Y. M. Park, H. Zhu +2
    bioRxivPreprintCC BYFull textOncologybioRxiv
  5. Tobacco Carcinogen Induces Persistent DNA Damage and Homologous Recombination Dysregulation in Pancreatic Ductal Carcinogenesis
    V. Krishnamoorthy, V. K. Gupta, S. Jinka +8
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  6. Pervasive expression of early embryonic programs in cancer has stage-dependent survival impact
    T. Wang, B. Hernandez-Rodriguez, J. A. Seneviratne +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  7. A microbiota-driven neuroepithelial feed-forward circuit drives gastroesophageal junction tumorigenesis
    Y. Zeng, Z. Ye, F. Wu +21
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  8. Preoperative thymic output and T cell repertoire diversity are associated with recurrence after nephrectomy for localized renal cell carcinoma
    C. E. Grand, L. Iisager, A. K. Attermann +12
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. Spatial Tumour Tissue Distribution Dynamics of a Bicycle Peptide-MMAE Toxin Conjugate Profiled by Targeted Mass Spectrometry
    M.-K. Ioannidi, S. Davis, T. He +8
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.
    Sriya Sridhar, Kabhilan Mohan, Smitha Kizhake +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  11. AMPK Signalling Rewires WWP1 mediated RUNX1 Ubiquitination in CML Progression
    A. Behera, S. C. Gorantla, E. R. Maddimadugu +5
    bioRxivPreprintCC BYFull textOncologybioRxiv
  12. THERAPY RESISTANCE IN MELANOMA DRIVES CILIOGENESIS AND GLUTAMINE/ASPARTATE METABOLISM DEPENDENCY
    P. Lugato, R. Castro, C. Thomas +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  13. Glyceraldehyde-3-phosphate sensing by SOS1 and RAS sustains a self-reinforcing oncogenic metabolic-signaling circuit
    R. Xia, H. Lei, C. Xiang +7
    bioRxivPreprintCC BYFull textOncologybioRxiv
  14. Host Determinants of Adjuvant Chemotherapy Initiation and Survival in Upper Gastrointestinal Adenocarcinoma
    B. Jiao, S. Alotaibi, K. Abumelha +12
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  15. Human-Guided Agentic AI for End-to-End EHR Research: Sequential Antibody-Drug Conjugate Pathways in Breast Cancer
    A. Loaiza-Bonilla, C. Colovos, D. Kim +3
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  16. Choroid plexus asymmetry on routine MRI as an imaging signature of breast cancer brain metastasis
    D. Lin, T. Zhu, X. Ma +13
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  17. Label-free machine learning detects a multi-cancer signal in a noninvasive urine and plasma metabolite panel: a case control study
    D. P. Patel, S. Chung, M. A. Khan +13
    medRxivPreprintCC BYFull textOncologymedRxivPMC
  18. Artificial intelligence and anti-cancer drugs: advancing discovery, personalization, and precision oncology
    Faizan ul Haque Nagrami, Pahchan Shukla, Ruchi Yadav +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  19. Functional biomarkers complementing static BRCA/HRD testing for dynamic PARP inhibitor therapy in ovarian cancer: a narrative review
    Tao Wu, Pengchuang Zhang, Ruxing Xi +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  20. Cancer-associated fibroblasts in triple-negative breast cancer: heterogeneity, tumor-stroma crosstalk, and therapeutic resistance
    Shijie Wei, Xiaoqing Xie, Yufeng Cao +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  21. Impact of Chile’s Explicit Health Guarantees Policy on breast cancer mortality: an interrupted time series analysis (1990–2024)
    Matilde Maddaleno Herrera, Christian García-Calavaro, Felipe Elorrieta +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  22. Self-reported practice patterns for cognitive preservation during whole-brain radiotherapy: a multinational cross-sectional survey of radiation oncologists in the Middle East and North Africa
    Renda AlHabib, Fahad AlRowais, Issa Mohamad +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  23. Efficacy and safety of sacituzumab govitecan in metastatic breast cancer: a single-center retrospective cohort study
    Orcun Can, Osman Gökhan Demir
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  24. Malignant potential of oral lichen planus without epithelial dysplasia: a systematic review and meta-analysis of longitudinal studies
    Carolina Brás Domingues, João Botelho, António Mano Azul +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  25. A nomogram integrating ultrasound features of the primary tumor and axillary lymph nodes with clinicopathological factors to predict high axillary lymph node burden in invasive breast cancer
    Xiuwei Li, Haocheng Qin, Yun’an Chen +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC